Raportointiselitykset

Raportointiselitykset

Etusivu / Lait ja asetukset / Raportointiselitykset
S.01.01 Content of the submission
Document
S.02.01 Balance sheet
Document
S.05.01 Prem., claims & exp. – lobs
Document
S.12.01 Life & health SLT TP
Document
S.17.01 Non-life & health NSLT TP
Document
S.23.01 Own funds
Document
S.25.01 SCR – Standard formula
Document
S.28.01 MCR – Non-composites
Document
G.01.01 Content of the submission
Document
G.02.01 Balance sheet
Document
S.01.01 Content of the submission
Document
S.02.01 Balance sheet
Document
S.05.01 Prem., claims & exp. – lobs
Document
S.12.01 Life & health SLT TP
Document
S.17.01 Non-life & health NSLT TP
Document
S.23.01 Own funds
Document
S.25.01 SCR – Standard formula
Document
S.28.01 MCR – Non-composites
Document
G.01.01 Content of the submission
Document
G.02.01 Balance sheet
Document
G.05.01 Prem., claims & exp. – lobs
Document
G.23.01 Own funds
Document
G.25.01 SCR – Standard formula
Document
SE.01.01 Content of the submission
Document
SE.02.01 Balance sheet
Document
SE.06.02 List of assets
Document
E.01.01 Deposits to cedants
Document
E.02.01 Pension entitlements
Document
E.04.01 Investment revenues and expenses
Document
G.05.01 Prem., claims & exp. – lobs
Document
G.23.01 Own funds
Document
G.25.01 SCR – Standard formula
Document
SE.01.01 Content of the submission
Document
SE.02.01 Balance sheet
Document
SE.06.02 List of assets
Document
E.01.01 Deposits to cedants
Document
E.02.01 Pension entitlements
Document
E.04.01 Investment revenues and expenses
Document

Asiakirjoja ei löytynyt

Tarkista lomakekoodi (esimerkiksi S.02.01) tai kokeile lyhyempää hakusanaa.

Puuttuuko lomake? Varaa esittely

EIOPA Solvency II

ECB E.01.01 Deposits to cedants ECB Taksonomia 2.8.0 ECB E.02.01 Pension entitlements ECB Taksonomia 2.8.0 ECB E.04.01 Investment revenues and expenses ECB Taksonomia 2.8.0 ECB SE.01.01 Content of the submission ECB Taksonomia 2.8.0 ECB SE.02.01 Balance sheet ECB Taksonomia 2.8.0 ECB SE.06.02 List of assets ECB Taksonomia 2.8.0 S.01.01 Content of the submission EIOPA Ryhmä Taksonomia 2.8.0 S.01.01 Content of the submission EIOPA Solo Taksonomia 2.8.0 S.01.02 Basic information EIOPA Ryhmä Taksonomia 2.8.0 S.01.02 Basic information EIOPA Solo Taksonomia 2.8.0 S.01.03 Basic information — RFF and matching adjustment portfolios EIOPA Ryhmä Taksonomia 2.8.0 S.01.03 Basic Information — RFF and matching adjustment portfolios EIOPA Solo Taksonomia 2.8.0 S.02.01 Balance sheet EIOPA Ryhmä Taksonomia 2.8.0 S.02.01 Balance sheet EIOPA Solo Taksonomia 2.8.0 S.02.02 Liabilities by currency EIOPA Ryhmä Taksonomia 2.8.0 S.02.02 Liabilities by currency EIOPA Solo Taksonomia 2.8.0 S.03.01 Off-balance sheet items — General EIOPA Ryhmä Taksonomia 2.8.0 S.03.01 Off-balance sheet items — General EIOPA Solo Taksonomia 2.8.0 S.04.02 Information on class 10 in Part A of Annex I of Solvency II Directive, excluding carrier's liability EIOPA Solo Taksonomia 2.8.0 S.04.03 Basic Information – List of underwriting entities EIOPA Solo Taksonomia 2.8.0 S.04.04 Activity by country – location of underwriting EIOPA Solo Taksonomia 2.8.0 S.04.05 Activity by country – location of risk EIOPA Solo Taksonomia 2.8.0 S.05.01 Premiums, claims and expenses by line of business EIOPA Ryhmä Taksonomia 2.8.0 S.05.01 Premiums, claims and expenses by line of business EIOPA Solo Taksonomia 2.8.0 S.05.02 Premiums, claims and expenses by country EIOPA Ryhmä Taksonomia 2.8.0 S.06.02 List of assets EIOPA Ryhmä Taksonomia 2.8.0 S.06.02 List of assets EIOPA Solo Taksonomia 2.8.0 S.06.03 Collective investment undertakings — look-through approach EIOPA Ryhmä Taksonomia 2.8.0 S.06.03 Collective investment undertakings — look-through approach EIOPA Solo Taksonomia 2.8.0 S.06.04 Climate change-related risks to investments EIOPA Solo Taksonomia 2.8.0 S.07.01 Structured products EIOPA Ryhmä Taksonomia 2.8.0 S.07.01 Structured products EIOPA Solo Taksonomia 2.8.0 S.08.01 Open derivatives EIOPA Ryhmä Taksonomia 2.8.0 S.08.01 Open derivatives EIOPA Solo Taksonomia 2.8.0 S.09.01 Information on gains / income and losses in the period EIOPA Ryhmä Taksonomia 2.8.0 S.09.01 Information on gains/income and losses in the period EIOPA Solo Taksonomia 2.8.0 S.10.01 Securities lending and repos EIOPA Ryhmä Taksonomia 2.8.0 S.10.01 Securities lending and repos EIOPA Solo Taksonomia 2.8.0 S.11.01 Assets held as collateral EIOPA Ryhmä Taksonomia 2.8.0 S.11.01 Assets held as collateral EIOPA Solo Taksonomia 2.8.0 S.12.01 Life and Health SLT Technical Provisions EIOPA Solo Taksonomia 2.8.0 S.12.02 Life and Health SLT Technical Provisions — by Country EIOPA Solo Taksonomia 2.8.0 S.13.01 Projection of future gross cash flows (Best Estimate — Life) EIOPA Solo Taksonomia 2.8.0 S.14.01 Life obligations analysis EIOPA Solo Taksonomia 2.8.0 S.14.02 Non-Life obligation analysis EIOPA Solo Taksonomia 2.8.0 S.14.03 Cyber underwriting risk EIOPA Solo Taksonomia 2.8.0 S.16.01 Information on annuities stemming from Non-Life Insurance obligations EIOPA Solo Taksonomia 2.8.0 S.17.01 Non-life Technical Provisions EIOPA Solo Taksonomia 2.8.0 S.17.03 Non-Life Technical Provisions — By country EIOPA Solo Taksonomia 2.8.0 S.18.01 Projection of future cash flows (Best Estimate — Non Life) EIOPA Solo Taksonomia 2.8.0 S.19.01 Non-life insurance claims EIOPA Solo Taksonomia 2.8.0 S.20.01 Development of the distribution of the claims incurred EIOPA Solo Taksonomia 2.8.0 S.21.01 Loss distribution risk profile EIOPA Solo Taksonomia 2.8.0 S.21.02 Underwriting risks non-life EIOPA Solo Taksonomia 2.8.0 S.21.03 Non-life distribution of underwriting underwriting risks — by sum insured EIOPA Solo Taksonomia 2.8.0 S.22.01 Impact of long term guarantees measures and transitionals EIOPA Solo Taksonomia 2.8.0 S.22.01 Impact of long-term guarantees measures and transitionals EIOPA Ryhmä Taksonomia 2.8.0 S.22.02 Projection of future cash flows (Best Estimate — Matching portfolios) EIOPA Solo Taksonomia 2.8.0 S.22.03 Information on the matching adjustment calculation EIOPA Solo Taksonomia 2.8.0 S.22.04 Information on the transitional on interest rates calculation EIOPA Solo Taksonomia 2.8.0 S.22.05 Overall calculation of the transitional on technical provisions EIOPA Solo Taksonomia 2.8.0 S.22.06 Best estimate subject to volatility adjustment by country and currency EIOPA Solo Taksonomia 2.8.0 S.23.01 Own Funds EIOPA Ryhmä Taksonomia 2.8.0 S.23.01 Own Funds EIOPA Solo Taksonomia 2.8.0 S.23.02 Detailed information by tiers on own funds EIOPA Ryhmä Taksonomia 2.8.0 S.23.02 Detailed information by tiers on own funds EIOPA Solo Taksonomia 2.8.0 S.23.03 Annual movements on own funds EIOPA Ryhmä Taksonomia 2.8.0 S.23.03 Annual movements on own funds EIOPA Solo Taksonomia 2.8.0 S.23.04 List of items on own funds EIOPA Ryhmä Taksonomia 2.8.0 S.23.04 List of items on own funds EIOPA Solo Taksonomia 2.8.0 S.24.01 Participations held EIOPA Solo Taksonomia 2.8.0 S.25.01 Solvency Capital Requirement — for groups on Standard Formula EIOPA Ryhmä Taksonomia 2.8.0 S.25.01 Solvency Capital Requirement — for undertakings on Standard Formula EIOPA Solo Taksonomia 2.8.0 S.25.05 Solvency Capital Requirement - for groups using an internal model (partial or full) EIOPA Ryhmä Taksonomia 2.8.0 S.25.05 Solvency Capital Requirement — for undertakings using an internal model (partial or full) EIOPA Solo Taksonomia 2.8.0 S.26.01 Solvency Capital Requirement — Market risk EIOPA Ryhmä Taksonomia 2.8.0 S.26.01 Solvency Capital Requirement — Market risk EIOPA Solo Taksonomia 2.8.0 S.26.02 Solvency Capital Requirement — Counterparty default risk EIOPA Ryhmä Taksonomia 2.8.0 S.26.02 Solvency Capital Requirement — Counterparty default risk EIOPA Solo Taksonomia 2.8.0 S.26.03 Solvency Capital Requirements — Life underwriting risk EIOPA Ryhmä Taksonomia 2.8.0 S.26.03 Solvency Capital Requirements — Life underwriting risk EIOPA Solo Taksonomia 2.8.0 S.26.04 Solvency Capital Requirement — Health underwriting risk EIOPA Ryhmä Taksonomia 2.8.0 S.26.04 Solvency Capital Requirement — Health underwriting risk EIOPA Solo Taksonomia 2.8.0 S.26.05 Solvency Capital Requirement — Non-Life underwriting risk EIOPA Ryhmä Taksonomia 2.8.0 S.26.05 Solvency Capital Requirement — Non-Life underwriting risk EIOPA Solo Taksonomia 2.8.0 S.26.06 Solvency Capital Requirements — Operational risk EIOPA Ryhmä Taksonomia 2.8.0 S.26.06 Solvency Capital Requirements — Operational risk EIOPA Solo Taksonomia 2.8.0 S.26.07 Solvency Capital Requirement — Simplifications EIOPA Ryhmä Taksonomia 2.8.0 S.26.07 Solvency Capital Requirement — Simplifications EIOPA Solo Taksonomia 2.8.0 S.26.08 Solvency Capital Requirement - for groups using an internal model (partial or full) EIOPA Ryhmä Taksonomia 2.8.0 S.26.08 Solvency Capital Requirement — for undertakings using an internal model (partial or full) EIOPA Solo Taksonomia 2.8.0 S.26.09 Internal model: Market & Credit risk – for financial instruments EIOPA Ryhmä Taksonomia 2.8.0 S.26.09 Internal model: Market and Credit risk – for financial instruments EIOPA Solo Taksonomia 2.8.0 S.26.10 Internal model: Credit event risk – portfolio view details EIOPA Ryhmä Taksonomia 2.8.0 S.26.10 Internal model: Credit event risk – portfolio view details EIOPA Solo Taksonomia 2.8.0 S.26.11 Internal model: Credit risk – details for financial instruments EIOPA Ryhmä Taksonomia 2.8.0 S.26.11 Internal model: Credit risk – details for financial instruments EIOPA Solo Taksonomia 2.8.0 S.26.12 Internal model: Credit risk – for non-financial instruments EIOPA Ryhmä Taksonomia 2.8.0 S.26.12 Internal model: Credit risk – for non-financial instruments EIOPA Solo Taksonomia 2.8.0 S.26.13 Internal model: Non-Life & Health NSLT Underwriting risk EIOPA Ryhmä Taksonomia 2.8.0 S.26.13 Internal model: Non-Life & Health NSLT Underwriting risk EIOPA Solo Taksonomia 2.8.0 S.26.14 Internal model: Life and Health underwriting risk EIOPA Ryhmä Taksonomia 2.8.0 S.26.14 Internal model: Life and Health underwriting risk EIOPA Solo Taksonomia 2.8.0 S.26.15 Internal model: Operational risk EIOPA Ryhmä Taksonomia 2.8.0 S.26.15 Internal model: Operational risk EIOPA Solo Taksonomia 2.8.0 S.26.16 Internal model - Model Changes EIOPA Ryhmä Taksonomia 2.8.0 S.26.16 Internal model - Model Changes EIOPA Solo Taksonomia 2.8.0 S.27.01 Solvency Capital Requirement — Non-life and health catastrophe risk EIOPA Ryhmä Taksonomia 2.8.0 S.27.01 Solvency Capital Requirement — Non-life and health catastrophe risk EIOPA Solo Taksonomia 2.8.0 S.28.01 Minimum Capital Requirement — Only life or only non-life insurance or reinsurance activity EIOPA Solo Taksonomia 2.8.0 S.28.02 Minimum Capital Requirement — Both life and non-life insurance activity EIOPA Solo Taksonomia 2.8.0 S.29.01 Excess of Assets over Liabilities EIOPA Solo Taksonomia 2.8.0 S.29.02 Excess of Assets over Liabilities — explained by investments and financial liabilities EIOPA Solo Taksonomia 2.8.0 S.29.03 Excess of Assets over Liabilities — explained by technical provisions EIOPA Solo Taksonomia 2.8.0 S.29.04 Detailed analysis per period — Technical flows versus Technical provisions EIOPA Solo Taksonomia 2.8.0 S.30.01 Facultative covers for non-life and life business basic data EIOPA Solo Taksonomia 2.8.0 S.30.02 Facultative covers for non-life and life business shares data EIOPA Solo Taksonomia 2.8.0 S.30.03 Outgoing Reinsurance Program basic data EIOPA Solo Taksonomia 2.8.0 S.30.04 Outgoing Reinsurance Program shares data EIOPA Solo Taksonomia 2.8.0 S.31.01 Share of reinsurers (including Finite Reinsurance and SPV's) EIOPA Ryhmä Taksonomia 2.8.0 S.31.01 Share of reinsurers (including Finite Reinsurance and SPV's) EIOPA Solo Taksonomia 2.8.0 S.31.02 Special Purpose Vehicles EIOPA Ryhmä Taksonomia 2.8.0 S.31.02 Special Purpose Vehicles EIOPA Solo Taksonomia 2.8.0 S.32.01 Undertakings in the scope of the group EIOPA Ryhmä Taksonomia 2.8.0 S.33.01 Insurance and reinsurance individual requirements EIOPA Ryhmä Taksonomia 2.8.0 S.34.01 Other regulated and non-regulated financial undertakings including insurance holding companies and mixed financial holding companies EIOPA Ryhmä Taksonomia 2.8.0 S.35.01 Contribution to group Technical Provisions EIOPA Ryhmä Taksonomia 2.8.0 S.36.01 IGT — Equity-type transactions, debt and asset transfer EIOPA Ryhmä Taksonomia 2.8.0 S.36.01 IGT — Equity-type transactions, debt and asset transfer EIOPA Solo Taksonomia 2.8.0 S.36.02 IGT — Derivatives EIOPA Ryhmä Taksonomia 2.8.0 S.36.02 IGT — Derivatives EIOPA Solo Taksonomia 2.8.0 S.36.03 IGT — Off-balance sheet and contingent liabilities EIOPA Ryhmä Taksonomia 2.8.0 S.36.03 IGT — Off-balance sheet and contingent liabilities EIOPA Solo Taksonomia 2.8.0 S.36.04 IGT — Insurance and Reinsurance EIOPA Ryhmä Taksonomia 2.8.0 S.36.04 IGT — Insurance and Reinsurance EIOPA Solo Taksonomia 2.8.0 S.36.05 IGT — P&L EIOPA Ryhmä Taksonomia 2.8.0 S.36.05 IGT — Profit and Loss EIOPA Solo Taksonomia 2.8.0 S.36.06 IGT — Off-balance sheet and contingent liabilities EIOPA Solo Taksonomia 2.8.0 S.36.07 IGT — Insurance and Reinsurance EIOPA Solo Taksonomia 2.8.0 S.37.01 Risk concentration – Exposure to Counterparties EIOPA Ryhmä Taksonomia 2.8.0 S.37.02 Risk Concentration – Exposure by currency, sector, country EIOPA Ryhmä Taksonomia 2.8.0 S.37.03 Risk Concentration — Exposure by asset class and rating EIOPA Ryhmä Taksonomia 2.8.0

BOE Insurance

AoC.01 Analysis of Change in Solvency Capital Requirement BOE PS 15/24 · 2024 IM.00 Internal model risk output - Content of the submission and Basic information BOE PS 15/24 · 2024 IM.01 Internal model outputs (life) BOE PS 15/24 · 2024 IM.02 Internal model counterparty risk BOE PS 15/24 · 2024 IM.03 Internal model outputs (non-life) BOE PS 15/24 · 2024 IR.01.01 Content of the submission BOE PS 15/24 · 2024 IR.01.02 Basic information BOE PS 15/24 · 2024 IR.01.03 Basic information – RFF and matching adjustment portfolios BOE PS 15/24 · 2024 IR.01.04 Basic information – Branch legal entity BOE PS 15/24 · 2024 IR.02.01 Balance sheet BOE PS 15/24 · 2024 IR.02.02 Assets and liabilities by currency BOE PS 15/24 · 2024 IR.02.03 Additional branch balance sheet information BOE PS 15/24 · 2024 IR.03.01 Off-balance sheet items — general BOE PS 15/24 · 2024 IR.03.02 Off-balance sheet items —unlimited guarantees received BOE PS 15/24 · 2024 IR.03.03 Off-balance sheet items — unlimited guarantees provided BOE PS 15/24 · 2024 IR.05.02 Premiums, claims and expenses by country BOE PS 15/24 · 2024 IR.05.03 Life income and expenditure BOE PS 15/24 · 2024 IR.05.04 Non-life income, expenditure and business model analysis BOE PS 15/24 · 2024 IR.05.05 Life premiums and claims by country BOE PS 15/24 · 2024 IR.05.06 Non-life premiums and claims by country BOE PS 15/24 · 2024 IR.05.07 Business model analysis - financial guarantee insurers BOE PS 15/24 · 2024 IR.05.08 Material pooling arrangements BOE PS 15/24 · 2024 IR.05.09 Assessable mutuals BOE PS 15/24 · 2024 IR.05.10 .01 – Excess capital generation BOE PS 15/24 · 2024 IR.06.02 List of assets BOE PS 15/24 · 2024 IR.06.03 Collective investment undertakings — look-through approach BOE PS 15/24 · 2024 IR.08.01 Open derivatives BOE PS 15/24 · 2024 IR.09.01 Information on income/gains and losses in the period BOE PS 15/24 · 2024 IR.10.01 Securities lending and repos BOE PS 15/24 · 2024 IR.11.01 Assets held as collateral BOE PS 15/24 · 2024 IR.12.01 Life technical provisions BOE PS 15/24 · 2024 IR.12.03 Life best estimate liabilities by country BOE PS 15/24 · 2024 IR.12.04 best estimate assumptions for life insurance risks BOE PS 15/24 · 2024 IR.12.05 with-profits value of bonus BOE PS 15/24 · 2024 IR.12.06 with-profits liabilities and assets BOE PS 15/24 · 2024 IR.14.01 Life obligations analysis BOE PS 15/24 · 2024 IR.16.01 Non-life annuities information BOE PS 15/24 · 2024 IR.16.02 Non-life annuities projection of future cash flows BOE PS 15/24 · 2024 IR.17.01 Non-life technical provisions BOE PS 15/24 · 2024 IR.17.03 Non-life best estimate liabilities by country BOE PS 15/24 · 2024 IR.18.01 Non-life projection of future cash flows BOE PS 15/24 · 2024 IR.18.02 Non-life liability projection of future cash flows BOE PS 15/24 · 2024 IR.19.01 .01 — Non-life insurance claims BOE PS 15/24 · 2024 IR.19.02 Non-life general liability claim development BOE PS 15/24 · 2024 IR.20.01 Development of the distribution of the claims incurred BOE PS 15/24 · 2024 IR.21.02 .01 — Non-life underwriting risks BOE PS 15/24 · 2024 IR.21.04 Cyber underwriting risk BOE PS 15/24 · 2024 IR.22.01 Impact of long term guarantees measures and transitionals BOE PS 15/24 · 2024 IR.22.04 Information on the transitional on interest rates calculation BOE PS 15/24 · 2024 IR.22.07 Best estimate subject to volatility adjustment by currency BOE PS 15/24 · 2024 IR.23.01 Own Funds BOE PS 15/24 · 2024 IR.23.02 Detailed information by tiers on own funds BOE PS 15/24 · 2024 IR.23.03 Annual movements on own funds BOE PS 15/24 · 2024 IR.23.04 List of items on own funds BOE PS 15/24 · 2024 IR.23.05 Society of Lloyd’s own funds and capital requirements BOE PS 15/24 · 2024 IR.24.01 Participations held BOE PS 15/24 · 2024 IR.25.04 Solvency Capital Requirement BOE PS 15/24 · 2024 IR.25.05 Solvency Capital Requirement – Partial or full internal model components BOE PS 15/24 · 2024 IR.25.06 Solvency Capital Requirement – loss-absorbing capacity of deferred taxes BOE PS 15/24 · 2024 IR.26.01 Solvency Capital Requirement – Market risk BOE PS 15/24 · 2024 IR.26.02 Solvency Capital Requirement – Counterparty default risk BOE PS 15/24 · 2024 IR.26.03 Solvency Capital Requirement – Life underwriting risk BOE PS 15/24 · 2024 IR.26.04 Solvency Capital Requirement – Health underwriting risk BOE PS 15/24 · 2024 IR.26.05 Solvency Capital Requirement — Non-Life underwriting risk BOE PS 15/24 · 2024 IR.26.06 Solvency Capital Requirement — Operational risk BOE PS 15/24 · 2024 IR.26.07 Solvency Capital Requirement — Simplifications BOE PS 15/24 · 2024 IR.27.01 Solvency Capital Requirement — Non-life and health catastrophe risk BOE PS 15/24 · 2024 IR.28.01 .01 — Minimum Capital Requirement — Only life or only non-life activity BOE PS 15/24 · 2024 IR.28.02 .01 — Minimum Capital Requirement — Both life and non-life activity BOE PS 15/24 · 2024 IR.30.03 Non-life outwards reinsurance contract information BOE PS 15/24 · 2024 IR.30.04 Non-life outwards reinsurance contract reinsurer exposures BOE PS 15/24 · 2024 IR.30.05 Reinsurer and collateral provider entity information BOE PS 15/24 · 2024 IR.30.06 Life outwards reinsurance summary BOE PS 15/24 · 2024 IR.30.07 Life outwards proportional reinsurance BOE PS 15/24 · 2024 IR.30.08 Life outwards non-proportional reinsurance BOE PS 15/24 · 2024 IR.31.01 Outwards reinsurance balance sheet exposures BOE PS 15/24 · 2024 IR.32.01 Undertakings in the scope of the group BOE PS 15/24 · 2024 IR.33.01 Insurance and reinsurance individual requirements BOE PS 15/24 · 2024 IR.34.01 Other regulated and non-regulated financial undertakings BOE PS 15/24 · 2024 IR.35.01 Contribution to group technical provisions BOE PS 15/24 · 2024 IR.36.01 IGT — equity-type transactions, debt and asset transfer BOE PS 15/24 · 2024 IR.36.02 IGT — derivatives BOE PS 15/24 · 2024 IR.36.04 IGT — cost sharing, contingent liabilities, off BS and other items BOE PS 15/24 · 2024 IRR.22.02 Matching adjustment portfolio projection of future cash flows BOE PS 15/24 · 2024 IRR.22.03 Matching adjustment calculation BOE PS 15/24 · 2024 MALIR – Matching adjustment asset and liability information return: Content of the submission, basic information and analytical data BOE PS 15/24 · 2024 MR.01.02 Market risk sensitivities BOE PS 15/24 · 2024 QMC.01 Quarterly model change BOE PS 15/24 · 2024

Pääsy Solvenssi II:een

Ja pysy ajan tasalla viimeisimmistä päivityksistä, taloudellisista tuloksista ja ilmoituksista